All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Y-MABS THERAPEUTICS, INC. earnings schedule

Y-MABS THERAPEUTICS, INC. quarterly earnings, YMAB earnings report for 2024. When does Y-MABS THERAPEUTICS, INC. report earnings?
Add to widgets
Added to widgets

When does Y-MABS THERAPEUTICS, INC. report earnings?

Y-MABS THERAPEUTICS, INC. reports earnings every quartal, last Y-MABS THERAPEUTICS, INC. earnings report date was 31/03/2021.

How much is Y-MABS THERAPEUTICS, INC. earnings per share?

Y-MABS THERAPEUTICS, INC. estimated earnings per share was 0.75 $ last time.

When is Y-MABS THERAPEUTICS, INC. next earnings report?

Next Y-MABS THERAPEUTICS, INC. earnings call will be in June 2024.

Y-MABS THERAPEUTICS, INC. earnings per share - the financial characteristics of the company on the size of its value. Earnings per share is calculated simply - all the company's profit for the reporting financial period divided by the number of shares. Obviously, Y-MABS THERAPEUTICS, INC. earnings per share is a variable indicator for a specific financial period. Profit of Y-MABS THERAPEUTICS, INC. - total profit for the reporting financial period.

Show:
to

Y-MABS THERAPEUTICS, INC. earnings report

All Y-MABS THERAPEUTICS, INC. profits are a reference. It is not so important to private shareholders. More important is the calculation of earnings per share. This value is the basis for calculating dividends and is much more in demand by the attention of shareholders. The date of the income statement of Y-MABS THERAPEUTICS, INC. is established by law and the rules of the organization. The dates of Y-MABS THERAPEUTICS, INC. profit statements for recent periods are shown in the table and graph of our online service.

Y-MABS THERAPEUTICS, INC. quarterly earnings

Earnings per share Y-MABS THERAPEUTICS, INC. is calculated according to the formula: net income divided by the total number of shares in the company. Earnings per share Y-MABS THERAPEUTICS, INC. is an indicator of a certain financial interval. It is easy to guess that the financial period coincides with the publication of financial statements of profit. Y-MABS THERAPEUTICS, INC. earnings per share for the most recent period are on the graph in the rightmost column. Quarterly profit Y-MABS THERAPEUTICS, INC. is the main type of financial statements among companies.

YMAB earnings date Estimated EPS
A company's earnings per share, or EPS, is calculated by dividing net income (or profits) to the number of company's shares.
Change for a year %
31/03/2021 0.75 USD -
31/12/2020 -0.48 USD -
30/09/2020 -0.82 USD +17.14% ↑
30/06/2020 -1.01 USD +90.57% ↑
30/09/2019 -0.7 USD -35.151% ↓
30/06/2019 -0.53 USD -
31/03/2019 -0.47 USD -
31/12/2018 -0.42 USD -
30/09/2018 -0.42 USD -

Y-MABS THERAPEUTICS, INC. quarterly earnings per share is a measure of the company's profitability. But it is less demanded than the profit for the year on one share. Last quarterly profit Y-MABS THERAPEUTICS, INC. is now considered to be quarterly profit for the last closed fiscal quarter of this year. The change in profit of Y-MABS THERAPEUTICS, INC. for the year is calculated in comparison with the same financial period as the current indicator only for the previous year. A change in Y-MABS THERAPEUTICS, INC. quarterly profit for the year is not so important as a change in Y-MABS THERAPEUTICS, INC. annual profit compared to last year.

The change in profit is shown as a percentage. In the table of the Quarterly Profit service on this page, you can find the history of Y-MABS THERAPEUTICS, INC. profit for previous reporting periods, for the last year or other interval. Y-MABS THERAPEUTICS, INC. quarterly earnings history is available online for each year and quarter over the past ten years. The Y-MABS THERAPEUTICS, INC. company’s profit database for previous years is collected from open sources.

Y-MABS THERAPEUTICS, INC. stocks data

Y-MABS THERAPEUTICS, INC. financials